Environmental risk assessments for medicinal products containing or consisting of genetically modified organisms (GMOs) (Module 1.6.2) Consultation document

Consultation document issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) in January 2005, concerning the application of the Centralised Procedure to Marketing Authorisation applications for medicinal products consisting of or containing GMOs as or in medicinal products. (Doc ref: EMEA/CMP/BWP/135148/2004)

• Primary Source